scholarly article | Q13442814 |
P50 | author | Benjamin K Tsang | Q42713839 |
Jihong Chen | Q42770849 | ||
Qiao Li | Q42770858 | ||
P2093 | author name string | S S Halappanavar | |
J R St-Germain | |||
P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy | Q28196495 | ||
Myonecrosis after revascularization procedures | Q28261530 | ||
Peri-procedural myocardial injury: 2005 update | Q36263844 | ||
Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes | Q39639379 | ||
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus | Q39734568 | ||
The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey | Q40582016 | ||
Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions | Q40926303 | ||
Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjects | Q42528977 | ||
The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation | Q43175089 | ||
Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults | Q43812092 | ||
Frequency and long-term impact of myonecrosis after coronary stenting | Q44012971 | ||
Platelet activation in obese women: role of inflammation and oxidant stress | Q44184883 | ||
Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention | Q44620714 | ||
The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome | Q46627029 | ||
The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation | Q47631189 | ||
AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance | Q47971254 | ||
Volumetric analysis of coronary plaque characterization in patients with metabolic syndrome using 64-slice multi-detector computed tomography. | Q53280655 | ||
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. | Q53891281 | ||
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita | Q58975824 | ||
Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome | Q79753554 | ||
Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions integrated backscatter intravascular ultrasound study | Q79970237 | ||
Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis | Q84182447 | ||
Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the 'obesity paradox' phenomenon is still apparent | Q84943581 | ||
Long-term effect of metabolic syndrome with and without diabetes mellitus on coronary revascularization in Japanese patients undergoing percutaneous coronary intervention | Q85085084 | ||
P433 | issue | 13 | |
P304 | page(s) | 1675-1683 | |
P577 | publication date | 2004-07-01 | |
P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
P1476 | title | Role of Akt/protein kinase B in the activity of transcriptional coactivator p300 | |
P478 | volume | 61 |
Q33733125 | A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma |
Q34461031 | A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells |
Q37696081 | Activation of GATA4 gene expression at the early stage of cardiac specification |
Q33925258 | Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity |
Q33695448 | B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation |
Q34013630 | Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association |
Q24537650 | Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development |
Q39528644 | Contribution of retinoid X receptor signaling to the specification of skeletal muscle lineage. |
Q35010007 | Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients |
Q38937837 | Effects of histone deacetylase inhibitor valproic acid on skeletal myocyte development. |
Q38797733 | Implication of retinoic acid receptor selective signaling in myogenic differentiation. |
Q35192970 | Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway. |
Q39096573 | Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation |
Q39699914 | Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes. |
Q39748724 | Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer |
Q40556837 | Molecular Basis for the Regulation of Transcriptional Coactivator p300 in Myogenic Differentiation. |
Q46422999 | Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells |
Q39017204 | PPARδ deficiency disrupts hypoxia-mediated tumorigenic potential of colon cancer cells |
Q46619121 | Pharmacologic profiling of transcriptional targets deciphers promoter logic |
Q39643895 | Promoter context determines the role of proteasome in ligand-dependent occupancy of retinoic acid responsive elements |
Q38876354 | Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling. |
Q42770821 | Regulation of Myf5 Early Enhancer by Histone Acetyltransferase p300 during Stem Cell Differentiation |
Q42706407 | Resveratrol inhibits Staphylococcus aureus-induced TLR2/MyD88/NF-κB-dependent VCAM-1 expression in human lung epithelial cells |
Q36548467 | Retinoid X Receptor-selective Signaling in the Regulation of Akt/Protein Kinase B Isoform-specific Expression |
Q35568845 | Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B |
Q33913340 | WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death |
Q30422684 | p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair |
Search more.